Crinetics’ PALSONIFY wins FDA approval as a new oral treatment for acromegaly, offering rapid, effective symptom control.
Several scientific studies suggest that resistance training has unique benefits in controlling obesity that go beyond what aerobic exercise, like walking, cycling alone, can do ...
In 2025, Wolfson Brands has unveiled an advanced line of Best fat-burning supplements for man designed to align with the ...
The U.S. Food and Drug Administration approved Crinetics Pharmaceuticals' drug to treat a rare hormonal disorder on Thursday, ...
An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” study, according to drugmaker uniQure, marking a major step toward a potential first genetic ...
Regeneron Pharmaceuticals, Inc., announced FDA approval of evinacumab-dgnb (Evkeeza) for children as young as 1 year of age with homozygous familial hypercholesterolemia (HoFH), expanding treatment ...
Survivors of high-risk neuroblastoma treated with modern therapies demonstrated a substantial burden of late effects, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback